DCM Shriram Fine Chemicals revises Urvashi Tilakdhar stake acquisition to 20.65%

2 min read     Updated on 25 Jul 2026, 05:42 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

DCM Shriram Fine Chemicals Ltd filed a revised disclosure on July 25, 2026, correcting the stake acquired by Urvashi Tilakdhar from 30.93% to 20.65%. The inter-family gift transaction involved shares from Madhav B. Shriram and the dissolved HUF of Lala Bansi Dhar & Sons. The aggregate promoter holding remains unchanged at 50.11%.

powered bylight_fuzz_icon
46506065

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals has issued a revised disclosure to correct an inadvertent clerical error in its previous intimation regarding the acquisition of shares by promoter Urvashi Tilakdhar. The updated filing, submitted on July 25, 2026, clarifies that Tilakdhar acquired a 20.65% stake in the company, rather than the previously reported 30.93%. The correction does not alter the aggregate promoter shareholding, which remains constant at 50.11%, nor does it change the nature of the transaction as an inter-family gift exempt from open offer obligations.

The revised submission under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, rectifies errors identified in the original disclosure filed on July 24, 2026. The company requested stock exchanges to ignore the earlier submission and record the corrected data. The acquisition involves shares transferred from Madhav Bansidhar Shriram and the dissolved Hindu Undivided Family (HUF) of Lala Bansi Dhar & Sons. The transaction was executed at NIL consideration, citing "inter-family gift out of love and affection" among immediate relatives.

Corrected Acquisition Details

The revised filing specifies that Urvashi Tilakdhar acquired 89,41,864 equity shares (10.28%) from Madhav B. Shriram and 90,21,200 equity shares (10.37%) from the dissolving HUF. This totals 20.65% of the company’s share capital. The volume-weighted average market price (VWAP) of the shares over the preceding 60 trading days was ₹25.42 per share. The exemption from making an open offer is claimed under Regulation 10(1)(a)(i) of the SEBI SAST Regulations, 2011, as the transfer occurs between immediate relatives.

Shareholder Pre-Acquisition Stake Shares Acquired/Transferred Post-Acquisition Stake
Urvashi Tilakdhar 6.77% 1,79,63,064 shares (20.65%) 27.42%
Madhav B. Shriram 10.28% Transferred all shares 0.00%
Lala Bansi Dhar & Sons (HUF) 13.83% Dissolved; shares transferred 0.00%
Suman Bansi Dhar 2.02% Acquired 30,07,067 shares from HUF 5.48%
Total Promoter Group 50.11% Internal Restructuring 50.11%

What the Numbers Show

The correction significantly adjusts the perceived concentration of ownership within the promoter group. While the initial report suggested Tilakdhar held nearly 38% of the company, the revised figure places her individual holding at 27.42%. Despite this adjustment, she remains the largest individual shareholder in the promoter group. The dissolution of the HUF and the subsequent distribution of its assets—primarily to Tilakdhar and Suman Bansi Dhar—streamlines the voting structure without diluting overall promoter control. The absence of monetary consideration confirms this is a structural realignment of family assets rather than a market-driven acquisition, signaling stable long-term promoter commitment with no immediate liquidity impact on the listed entity.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.44%-1.37%+7.72%-46.84%-46.84%-46.84%

How might the streamlined voting structure and consolidation of promoter holdings under Urvashi Tilakdhar influence future corporate governance decisions or strategic direction at DCM Shriram?

Could the dissolution of the Lala Bansi Dhar & Sons HUF trigger any tax implications or regulatory scrutiny regarding the valuation of assets transferred between immediate relatives?

Given the correction of a significant clerical error in a SEBI filing, what enhanced compliance measures might DCM Shriram implement to ensure accuracy in future regulatory disclosures?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like18
dislike

DCM Shriram Fine Chemicals accepts Aditi Dhar resignation

1 min read     Updated on 20 Jul 2026, 10:13 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

DCM Shriram Fine Chemicals Ltd has accepted the resignation of Ms. Aditi Dhar as Director (Non-Executive Non Independent) effective July 17, 2026, citing personal reasons and the inability to participate in Board proceedings from the UK. The company disclosed this to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered bylight_fuzz_icon
45837439

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals Ltd has accepted the resignation of Ms. Aditi Dhar as Director (Non-Executive Non Independent) effective July 17, 2026. The resignation was submitted due to personal reasons, as she is based in the UK and it is not feasible for her to participate in the Board proceedings.

The disclosure was made to the stock exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the resignation is with immediate effect.

Details of Resignation

The following table outlines the key details regarding the change in directorship:

Sr. No. Particulars Details
1 Reason for Change Resignation of Ms. Aditi Dhar (DIN: 10844764) as a Director (Non-Executive Non Independent) of the Company due to the reasons as provided in her resignation letter.
2 Date of Cessation 17 July, 2026
3 Brief Profile Not Applicable
4 Disclosure of relationships between directors Not Applicable

Ms. Dhar requested the Board to take the necessary steps to acknowledge her resignation and ensure all regulatory and procedural formalities, including filings with the relevant authorities, are completed.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.44%-1.37%+7.72%-46.84%-46.84%-46.84%

Who will be appointed to fill the vacancy left by Ms. Dhar, and what expertise will they bring?

How will the board's strategic focus shift following this resignation?

Will this change impact the company's governance structure or decision-making process?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like15
dislike

More News on DCM Shriram Fine Chemicals

1 Year Returns:-46.84%